NASDAQ GlobeNewswire | TalkMarkets | Page 11
Media Intelligence
Contributor's Links: Nasdaq GlobeNewswire
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

All Contributions

Latest Posts
161 to 176 of 490 Posts
<<< 1 ... 9 10 11 12 13 ... 31 >>>
Endocyte Announces Pricing Of Public Offering Of Common Stock
Endocyte, Inc. today the pricing of an underwritten registered public offering of 17,857,143 shares of its common stock at a price to the public of $4.20 per share.
NMI Holdings, Inc. Announces Proposed Public Offering Of Common Stock
NMI Holdings, Inc. today announced it has commenced an underwritten registered public offering of 3,700,000 shares of its Class A common stock, par value $0.01 per share.
WisdomTree Announces Changes To ETF Family
WisdomTree (WETF​), an exchange-traded fund and exchange-traded product sponsor and asset manager, today announced plans to close and liquidate nine of its ETFs. The Funds will no longer accept creation orders after Friday, March 16, 2018.
Catalyst Biosciences Announces Closing Of Public Offering Of Common Stock
Catalyst Biosciences, today announced the closing of an underwritten public offering of 3,382,352 shares of its common stock, offered at a price of $34.00 per share to the public.
Inpixon Prices $18M Public Offering
INPIXON today announced the pricing of a public offering with anticipated gross proceeds of approximately $18 million, before deducting placement agent fees and other offering expenses.
Catalyst Biosciences Announces The Pricing Of Public Offering Of Common Stock
Catalyst Biosciences, Inc. today announced the pricing of an underwritten public offering of 2,941,176 shares of its common stock, offered at a price of $34.00 per share to the public.
Pacific Biosciences Of California, Inc. Announces Proposed Public Offering Of Common Stock
Pacific Biosciences of California, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
Daseke, Inc. Announces Follow-On Public Offering Of Common Stock
Daseke, Inc. today announced the commencement of an underwritten public offering of 7,420,000 shares of its common stock by the Company and 80,000 shares of its common stock by one of the Company’s stockholders.
Gemphire Announces Pricing Of $22 Million Public Offering Of Common Stock
Gemphire Therapeutics Inc. today announced the pricing of its previously announced underwritten public offering of 3,142,858 shares of its common stock at a public offering price of $7.00 per share.
Nasdaq Reports Fourth Quarter And Full Year 2017 Results; Delivers Strong Revenue And Income Growth
2017 net revenues were $2,428 million, an increase of 7% compared to 2016. Subscription and recurring revenues increased 7% in 2017 compared to the prior year, and represented 76% of total net revenues.
Fidus Investment Corporation Announces Public Offering Of Notes
Fidus Investment Corporation today announced the commencement of a registered public offering of unsecured notes due 2023 (the “Notes”), subject to market and other conditions.
Iovance Biotherapeutics, Inc. Announces Closing Of $172.5 Million Common Stock Public Offering
Iovance Biotherapeutics, Inc. today announced the closing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $11.50 per share.
First Majestic Completes US$150 Million Convertible Senior Notes Offering
First Majestic Silver Corp. announced today the closing of its previously announced offering of US$150 million aggregate principal amount of 1.875% unsecured convertible senior notes due 2023.
Iovance Biotherapeutics, Inc. Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock
Iovance Biotherapeutics, Inc. today announced the pricing of an underwritten public offering of 13,043,479 shares of its common stock at a public offering price of $11.50 per share.
HTG Molecular Diagnostics Announces Proposed Public Offering Of Common Stock
HTG Molecular Diagnostics, Inc. today announced that it intends to offer and sell, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering.
AveXis Announces Proposed Public Offering Of Common Stock
AveXis, Inc. today announced that it intends to offer and sell, subject to market conditions, up to $400 million of shares of its common stock in an underwritten public offering.
161 to 176 of 490 Posts
<<< 1 ... 9 10 11 12 13 ... 31 >>>